Financial Results for the Quarter and Nine Months Ended 31st December 2025
Awaiting price reaction for this filing.
Soni Medicare Ltd reported a net loss of Rs 113.12 lakhs for Q3 FY26 (Oct-Dec 2025), wider than the Rs 13.31 lakh loss in the same quarter last year. For the nine months ended December 2025, the loss deepened to Rs 234.17 lakhs versus Rs 53.34 lakhs a year ago. Revenue from operations fell to Rs 536.49 lakhs in Q3 from Rs 752.36 lakhs in Q3 FY25, a drop of about 28.7%, while nine-month revenue declined to Rs 1,887.67 lakhs from Rs 2,297 lakhs. Total expenses of Rs 678.20 lakhs in Q3 far exceeded total income of Rs 565.48 lakhs, and the company also carries a basic EPS of Rs -2.65 for the quarter. The results were approved by the Board on 14 February 2026 with a clean limited review report from the auditors and no qualifications.
Sharply falling revenue and widening losses are negative for shareholders — the company is losing more money on a smaller top line, which raises concerns about business momentum and could weigh on the stock price in the near term.